Aim Immunotech Stock Price Prediction
| AIM Stock | USD 0.23 0.02 9.52% |
Oversold Vs Overbought
33
Oversold | Overbought |
EPS Estimate Next Quarter (0.10) | EPS Estimate Current Year (0.37) | EPS Estimate Next Year (0.39) | Wall Street Target Price 3 | EPS Estimate Current Quarter (0.09) |
Using AIM ImmunoTech hype-based prediction, you can estimate the value of AIM ImmunoTech from the perspective of AIM ImmunoTech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in AIM ImmunoTech to buy its stock at a price that has no basis in reality. In that case, they are not buying AIM because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
AIM ImmunoTech after-hype prediction price | USD 0.23 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
AIM |
AIM ImmunoTech After-Hype Price Prediction Density Analysis
As far as predicting the price of AIM ImmunoTech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AIM ImmunoTech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of AIM ImmunoTech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
AIM ImmunoTech Estimiated After-Hype Price Volatility
In the context of predicting AIM ImmunoTech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AIM ImmunoTech's historical news coverage. AIM ImmunoTech's after-hype downside and upside margins for the prediction period are 0.01 and 5.46, respectively. We have considered AIM ImmunoTech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
AIM ImmunoTech is extremely dangerous at this time. Analysis and calculation of next after-hype price of AIM ImmunoTech is based on 3 months time horizon.
AIM ImmunoTech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as AIM ImmunoTech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AIM ImmunoTech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AIM ImmunoTech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.52 | 5.19 | 0.00 | 0.03 | 9 Events / Month | 14 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.23 | 0.23 | 0.00 |
|
AIM ImmunoTech Hype Timeline
On the 1st of December AIM ImmunoTech is traded for 0.23. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. AIM is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.52%. %. The volatility of related hype on AIM ImmunoTech is about 10479.81%, with the expected price after the next announcement by competition of 0.20. About 14.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.47. AIM ImmunoTech last dividend was issued on the 11th of June 2019. The entity had 1:44 split on the 11th of June 2019. Considering the 90-day investment horizon the next forecasted press release will be in about 9 days. Check out AIM ImmunoTech Basic Forecasting Models to cross-verify your projections.AIM ImmunoTech Related Hype Analysis
Having access to credible news sources related to AIM ImmunoTech's direct competition is more important than ever and may enhance your ability to predict AIM ImmunoTech's future price movements. Getting to know how AIM ImmunoTech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AIM ImmunoTech may potentially react to the hype associated with one of its peers.
AIM ImmunoTech Additional Predictive Modules
Most predictive techniques to examine AIM price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AIM using various technical indicators. When you analyze AIM charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About AIM ImmunoTech Predictive Indicators
The successful prediction of AIM ImmunoTech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as AIM ImmunoTech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of AIM ImmunoTech based on analysis of AIM ImmunoTech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to AIM ImmunoTech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AIM ImmunoTech's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 4.4K | 4.3K | 2.1K | 2.2K | PTB Ratio | 0.77 | 0.39 | 2.09 | 1.98 |
Story Coverage note for AIM ImmunoTech
The number of cover stories for AIM ImmunoTech depends on current market conditions and AIM ImmunoTech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AIM ImmunoTech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AIM ImmunoTech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
AIM ImmunoTech Short Properties
AIM ImmunoTech's future price predictability will typically decrease when AIM ImmunoTech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AIM ImmunoTech often depends not only on the future outlook of the potential AIM ImmunoTech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AIM ImmunoTech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.6 M | |
| Cash And Short Term Investments | 13.1 M |
Check out AIM ImmunoTech Basic Forecasting Models to cross-verify your projections. To learn how to invest in AIM Stock, please use our How to Invest in AIM ImmunoTech guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AIM ImmunoTech. If investors know AIM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AIM ImmunoTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.004 | Quarterly Revenue Growth 0.19 | Return On Assets (0.80) | Return On Equity (1.55) |
The market value of AIM ImmunoTech is measured differently than its book value, which is the value of AIM that is recorded on the company's balance sheet. Investors also form their own opinion of AIM ImmunoTech's value that differs from its market value or its book value, called intrinsic value, which is AIM ImmunoTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AIM ImmunoTech's market value can be influenced by many factors that don't directly affect AIM ImmunoTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AIM ImmunoTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if AIM ImmunoTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AIM ImmunoTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.